✦ LIBER ✦

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Pan-European trial comparing

✍ U. Gatzemeier; R. Rosell; D. Betticher; U. Keppler; H.N. Macha; R. Pirker; P. Be 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

794 Weekly paclitaxel (W-PAC) as second-

✍ G.L. Ceresoli; V. Gregorc; S. Cordio; K. Bencardino; A. Spreafico; C. Cozzarini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II study of paclitaxel (Genaxol®)

✍ Chen, Chih-Hung; Chang, Wen-Cheng; Lin, Meng-Chin; Hsu, Jen-Wen; Chao, Tsu-Yi; T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

128 Preliminary results of a phase II st

✍ Pérol, M.; Souquet, P.J.; Riou, R.; Fournel, P.; Dussopt, C.; Vuillermoz, S.; Bo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Phase I and pharmacokinetics trial of BN

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Cisplatin — gemcitabine — paclitaxel (PG

✍ G. Frasci; P. Comella; N. Panza; G. Nicolella; D. Bilancia; R. Cioffi; E. Micill 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB